REEV SENSE for Gait Analysis in Post-stroke Gait Impairment (SENS-AG)
SENS-AG
Validation of REEV SENSE Biomarkers Precision for Gait Analysis in Subjects With Post-stroke Gait Impairment
1 other identifier
interventional
23
1 country
1
Brief Summary
The purpose of this study is to evaluate the clinical performance of the investigational REEV SENSE gait tracker to measure gait features in subjects with post-stroke gait impairment. REEV SENSE is intended to be used by trained healthcare professionals as a simple procedure adapted to clinical routine. The reference method for performance comparison will be motion capture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2023
CompletedStudy Start
First participant enrolled
January 8, 2024
CompletedFirst Posted
Study publicly available on registry
January 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedApril 15, 2025
April 1, 2025
1.1 years
December 15, 2023
April 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Walking speed measure precision
Comparison of walking speed measured with REEV SENSE with reference method
Throughout study completion (an average of 2h)
Secondary Outcomes (8)
KPP (Knee Position Predictor) measure precision = precision of the predicted angle of knee sagittal flexion in the next 200ms
Throughout study completion (an average of 2h)
Walking cadence measure precision = precision of the number of steps per minute
Throughout study completion (an average of 2h)
Stride length measure precision
Throughout study completion (an average of 2h)
Swing time measure precision
Throughout study completion (an average of 2h)
Stance time measure precision
Throughout study completion (an average of 2h)
- +3 more secondary outcomes
Study Arms (1)
Gait analysis
EXPERIMENTALGait analysis with the investigational and the reference devices
Interventions
Eligibility Criteria
You may qualify if:
- Post-stroke gait disorder.
- Must be able to walk independently with or without the support of a cane or rollator.
- History of stroke more than six months ago.
- Be 18 years of age or older.
You may not qualify if:
- Subject unable to give consent.
- Subject unable to understand the tests.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- REEV LLClead
Study Sites (1)
MIT Center for Clinical and Translational Research
Cambridge, Massachusetts, 02139, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2023
First Posted
January 31, 2024
Study Start
January 8, 2024
Primary Completion
March 1, 2025
Study Completion
April 1, 2025
Last Updated
April 15, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share